If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Background The role of female-specific factors in the occurrence and progression of cardiometabolic disease (CMD) across ...

Aims Cardiovascular (CV) deaths were reduced by atorvastatin during a 16-year follow-up of participants in the ...

Background Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience worsening cardiac disease (WCD) ...

aDepartment of Pediatrics, Carnegie Building #291, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287-6220, USA, bDepartment of Pathology, The Johns Hopkins University School of ...

Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, North Carolina, USA Correspondence to Dr James P ...

a Department of Cardiology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK, b Department of Medical Genetics, Aberdeen Royal Infirmary Three patients with Emery Dreifuss muscular ...

Background Cardiac cachexia is a condition characterised by unintentional weight loss and muscle wasting in patients with ...

Background Population-based coronary heart disease (CHD) studies have focused on myocardial infarction (MI) with limited data on trends across the spectrum of CHD. We investigated trends in ...

Background The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with adverse ...

Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of patients with heart failure with reduced left ventricular ejection fraction (HFrEF). However, RAAS ...

1 Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia 2 Department of Cardiology, Royal Melbourne Hospital and the Department of Medicine, ...